{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:26:38Z","timestamp":1782512798509,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/bf00613521","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T04:23:31Z","timestamp":1101356611000},"page":"437-442","source":"Crossref","is-referenced-by-count":9,"title":["Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate"],"prefix":"10.1007","volume":"31","author":[{"given":"H.","family":"Saner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Gurtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Preisig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"K\ufffdpfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","volume-title":"Primary pulmonary hypertension","author":"S Hatano","year":"1975","unstructured":"Hatano S, Strasser T (1975) Primary pulmonary hypertension. Report on a WHO meeting. Geneva, October 15?17, 1973. WHO, Geneva"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","volume":"18","author":"D Heath","year":"1958","unstructured":"Heath D, Edwards JE (1958) The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18: 533","journal-title":"Circulation"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/01.CIR.42.6.1163","volume":"42","author":"CA Wagenvoort","year":"1970","unstructured":"Wagenvoort CA, Wagenvoort N (1970) Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 42: 1163","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.CIR.56.5.884","volume":"56","author":"WD Edwards","year":"1977","unstructured":"Edwards WD, Edwards JE (1977) Clinical primary pulmonary hypertension. Three pathologic types. Circulation 56: 884","journal-title":"Circulation"},{"key":"CR5","first-page":"1579","volume":"98","author":"HP Gurtner","year":"1968","unstructured":"Gurtner HP, Gertsch M, Salzmann C, Scherrer M, Stucki P, Wyss F (1968) H\u00e4ufen sich die prim\u00e4r vascul\u00e4ren Formen des chronischen Cor pulmonale? Schweiz Med Wochenschr 98: 1579","journal-title":"Schweiz Med Wochenschr"},{"key":"CR6","first-page":"2146","volume":"100","author":"P Wirz","year":"1970","unstructured":"Wirz P, Arbenz U (1970) Prim\u00e4r vascul\u00e4re pulmonale Hypertonie in der Schweiz, 1965?1970. Schweiz Med Wochenschr 100: 2146","journal-title":"Schweiz Med Wochenschr"},{"key":"CR7","first-page":"373","volume":"83","author":"F Kaindl","year":"1971","unstructured":"Kaindl F (1971) Medikament\u00f6s bedingte pulmonale Hypertonie. Erfahrungen in \u00d6sterreich. Wien Klin Wochenschr 83: 373?375","journal-title":"Wien Klin Wochenschr"},{"key":"CR8","first-page":"1","volume":"65","author":"F Loogen","year":"1976","unstructured":"Loogen F, Both A (1976) Prim\u00e4re pulmonale Hypertonie. Z. Kardiol 65: 1","journal-title":"Z. Kardiol"},{"key":"CR9","first-page":"21","volume":"100","author":"R Blankart","year":"1970","unstructured":"Blankart R (1970) Der Zeitfaktor im Ablauf der prim\u00e4r vaskul\u00e4ren pulmonalen Hypertonie. Schweiz Med Wochenschr 100: 21","journal-title":"Schweiz Med Wochenschr"},{"key":"CR10","first-page":"437","volume":"14","author":"E Greiser","year":"1973","unstructured":"Greiser E (1973) Epidemiologische Untersuchungen zum Zusammenhang zwischen Appetitz\u00fcglereinnahme und prim\u00e4r vascul\u00e4rer pulmonaler Hypertonie. Internist 14: 437","journal-title":"Internist"},{"key":"CR11","first-page":"2154","volume":"100","author":"K Gahl","year":"1970","unstructured":"Gahl K, Greiser E (1970) Erfahrungen einer klinisch-epidemiologischen Studie zum Problem der prim\u00e4r vascul\u00e4ren pulmonalen Hypertonie. Schweiz Med Wochenschr 100: 2154","journal-title":"Schweiz Med Wochenschr"},{"key":"CR12","first-page":"902","volume":"59","author":"M Gertsch","year":"1970","unstructured":"Gertsch M, Stucki P (1970) Weitgehend reversible prim\u00e4r vaskul\u00e4re pulmonale Hypertonie bei Patienten mit Menocil-Einnahme. Z Kreislaufforsch 59: 902","journal-title":"Z Kreislaufforsch"},{"key":"CR13","first-page":"1794","volume":"103","author":"O Bass","year":"1973","unstructured":"Bass O, Gurtner HP (1973) Verlauf der prim\u00e4r vaskul\u00e4ren pulmonalen Hypertonie nach Einnahme von Aminorexfumarat (Menocil). Schweiz Med Wochenschr 103: 1794","journal-title":"Schweiz Med Wochenschr"},{"key":"CR14","first-page":"782","volume":"115","author":"HP Gurtner","year":"1985","unstructured":"Gurtner HP (1985) Chronische pulmonale Hypertonie vaskul\u00e4ren Ursprungs, plexogene pulmonale Arteropathie und der Appetitz\u00fcgler Aminorex: Nachlese zu einer Epidemie. Schweiz Med Wochenschr 115: 782?789 und 818?827","journal-title":"Schweiz Med Wochenschr"},{"key":"CR15","first-page":"787","volume":"65","author":"JL Rivier","year":"1972","unstructured":"Rivier JL, Jaeger M, Reymond CL, Desbaillets P (1972) Hypertension art\u00e9rielle pulmonaire primitive et anorexigene. Arch Mal Coeur 65: 787","journal-title":"Arch Mal Coeur"},{"key":"CR16","first-page":"2152","volume":"100","author":"J Laissue","year":"1970","unstructured":"Laissue J (1970) Ergebnisse pathologisch-anatomischer Untersuchungen bei Patienten mit prim\u00e4r vascul\u00e4rer pulmonaler Hypertonie. Schweiz Med Wochenschr 100: 2152","journal-title":"Schweiz Med Wochenschr"},{"key":"CR17","first-page":"1","volume-title":"Current topics in pathology","author":"S Widgren","year":"1977","unstructured":"Widgren S (1977) Pulmonary hypertension related to Aminorex intake. In: Grundmann E, Kirsten WH (eds) Current topics in pathology. Springer, Berlin, S 1?64"},{"key":"CR18","first-page":"2154","volume":"100","author":"O Kraupp","year":"1970","unstructured":"Kraupp O, St\u00fchlinger W, Turnheim K (1970) Vergleichende Untersuchungen \u00fcber die Wirkung von Aminorex, Ephedrin, Noradrenalin, Amphetamin und N-Chlorpropylamphetamin auf die H\u00e4modynamik des gro\u00dfen und kleinen Kreislaufes an Hunden. Schweiz Med Wochenschr 100: 2154","journal-title":"Schweiz Med Wochenschr"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01002378","volume":"264","author":"O Kraupp","year":"1969","unstructured":"Kraupp O, St\u00fchlinger W, Raberger G, Thurnheim K (1969) Die Wirkung von Aminorex (Menocil) auf die H\u00e4modynamik des kleinen und gro\u00dfen Kreislaufs bei i.v.-Darreichung am Hund. Naunyn-Schmiedebergs Arch Pharmacol 264: 389","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/BF00997942","volume":"266","author":"H Brunner","year":"1970","unstructured":"Brunner H, Stepanek J (1970) Drucksteigerungen im kleinen Kreislauf des Hundes durch Aminorex. Naunyn-Schmiedebergs Arch Pharmacol 266: 304","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/thx.26.3.262","volume":"26","author":"JM Kay","year":"1971","unstructured":"Kay JM, Smith P, Heath D (1971) Aminorex and the pulmonary circulation. Thorax 26: 262","journal-title":"Thorax"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/thx.27.1.127","volume":"27","author":"E Byrne-Quinn","year":"1972","unstructured":"Byrne-Quinn E, Grover RF (1972) Aminorex (Menocil) and amphetamine: Acute and chronic effects on pulmonary and systemic hemodynamics in the calf. Thorax 27: 127","journal-title":"Thorax"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/7.1.30","volume":"7","author":"P Smith","year":"1973","unstructured":"Smith P, Heath D, Kay JM, Wright JS, McKendrick (1973) Pulmonary arterial pressure and structure in the patas monkey after prolonged administration of aminorex fumarate. Cardiovasc Res 7: 30","journal-title":"Cardiovasc Res"},{"key":"CR24","first-page":"1793","volume":"103","author":"J Stepanek","year":"1973","unstructured":"Stepanek J (1973) Pulmonale Hypertonie nach chronischer Aminorexgabe beim Hund. Schweiz Med Wochenschr 103: 1793","journal-title":"Schweiz Med Wochenschr"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF00541938","volume":"26","author":"A K\u00fcpfer","year":"1984","unstructured":"K\u00fcpfer A, Preisig R (1984) Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man. Eur J Clin Pharmacol 26: 753","journal-title":"Eur J Clin Pharmacol"},{"key":"CR26","first-page":"590","volume":"221","author":"A K\u00fcpfer","year":"1982","unstructured":"K\u00fcpfer A, Desmond PV, Schenker S, Branch RA (1982) Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. J Pharmacol Exp Ther 221: 590","journal-title":"J Pharmacol Exp Ther"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/0006-2952(82)90549-4","volume":"31","author":"A K\u00fcpfer","year":"1982","unstructured":"K\u00fcpfer A, Al-Dabbagh SG, Ritchie JC, Idle JR, Smith RL (1982) Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains. Biochem Pharmacol 31: 3193","journal-title":"Biochem Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2165\/00003495-198529040-00003","volume":"29","author":"DWJ Clark","year":"1985","unstructured":"Clark DWJ (1985) Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29: 342","journal-title":"Drugs"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bmj.284.6312.295","volume":"284","author":"RR Shah","year":"1982","unstructured":"Shah RR, Oates NS, Idle JR, Smith RL, Lockhart JDF (1982) Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J 284: 295","journal-title":"Br Med J"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.20.3.186","volume":"20","author":"D Lewis","year":"1979","unstructured":"Lewis D, Wainwright HC, Kew MC, Zwi S, Isaacson C (1979) Liver damage associated with perhexiline maleate. Gut 20: 186","journal-title":"Gut"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/hrt.35.8.824","volume":"35","author":"M Fahl\u00e9n","year":"1973","unstructured":"Fahl\u00e9n M, Be Bergman H, Helder G, Ryden L, Wallentin L, Zettergren L (1973) Phenformin and pulmonary hypertension. Br Heart J 35: 824","journal-title":"Br Heart J"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/bmj.292.6515.239-a","volume":"292","author":"J McMurray","year":"1986","unstructured":"McMurray J, Bloomfield P, Miller HC (1986) Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J 292: 240","journal-title":"Br Med J"},{"key":"CR33","doi-asserted-by":"crossref","unstructured":"Toxic epidemic syndrome study group, Spain. Toxic epidemic syndrome, Spain, 1981. Lancet 2: 697","DOI":"10.1016\/S0140-6736(82)90721-8"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0022-3476(73)80530-X","volume":"83","author":"OR Levine","year":"1973","unstructured":"Levine OR, Harris RS, Blanc WA, Mellins RB (1973) Progressive pulmonary hypertension in children with portal hypertension. J Pediatr 83: 964","journal-title":"J Pediatr"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/hrt.30.4.575","volume":"30","author":"N Segel","year":"1968","unstructured":"Segel N, Kay JM, Bayley TJ, Paton A (1968) Pulmonary hypertension with hepatic cirrhosis. Br Heart J 30: 575","journal-title":"Br Heart J"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.37.1.88","volume":"37","author":"RM Senior","year":"1968","unstructured":"Senior RM, Britton RC, Turino GM, Wood JA, Langer GA, Fishman AP (1968) Pulmonary hypertension associated with cirrhosis of the liver and with portocaval shunts. Circulation 37: 88","journal-title":"Circulation"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.RES.35.5.657","volume":"35","author":"AP Fishman","year":"1974","unstructured":"Fishman AP (1974) Dietary pulmonary hypertension. Circ Res 35: 657","journal-title":"Circ Res"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.CIR.22.1.154","volume":"22","author":"HO Heinemann","year":"1960","unstructured":"Heinemann HO (1960) Respiration and circulation in patients with portal cirrhosis of the liver. Circulation 22: 154","journal-title":"Circulation"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-8703(63)90062-0","volume":"66","author":"RF Grover","year":"1963","unstructured":"Grover RF, Vogel JHK, Averill KH, Blount SG Jr (1963) Pulmonary hypertension. Individual and species variability relative to vascular reactivity. Am Heart J 66: 1","journal-title":"Am Heart J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00613521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00613521\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00613521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T08:36:35Z","timestamp":1585989395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00613521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1986]]}},"alternative-id":["BF00613521"],"URL":"https:\/\/doi.org\/10.1007\/bf00613521","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986]]}}}